| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 875,720 | 884,502 |
| Accounts receivable | -37,073 | 289,728 |
| Inventory | 699,181 | 190,200 |
| Deferred revenue | 86,662 | 224,330 |
| Accrued services | 693 | 18,507 |
| Accounts payable | 1,939 | 8,410 |
| Prepaid expenses | 30,032 | 42,502 |
| Net cash provided by (used in) operating activities | 272,874 | 613,319 |
| Purchase of intangible assets | 46,064 | 46,064 |
| Advances from related parties | 2,422,096 | 1,391,635 |
| Repayment to related parties | 2,172,000 | 1,322,000 |
| Proceeds from the sale of common stock | 0 | 0 |
| Net cash provided by financing activities | 250,096 | 69,635 |
| Net increase in cash | 476,906 | 636,890 |
| Cash and cash equivalents at end of period | 1,139,423 | - |
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)